Beam Therapeutics (BEAM) Earnings Date, Estimates & Call Transcripts $24.50 -0.55 (-2.20%) (As of 09/30/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 13EstimatedActual EPS (Aug. 6) -$1.11 Beat By $0.02 Consensus EPS (Aug. 6) -$1.13 Conference Call TranscriptConference Call AudioEarnings Press Release Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBEAM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BEAM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyThe world’s smartest man is in their crosshairsElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, Beam Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($1.31)($1.18)($1.26)Q2 20243($1.24)($0.91)($1.08)Q3 20244($1.23)($0.94)($1.09)Q4 20244($1.22)($0.94)($1.05)FY 202414($5.00)($3.97)($4.48)Q1 20253($0.98)($0.90)($0.95)Q2 20253($1.00)($0.90)($0.93)Q3 20253($0.96)($0.84)($0.90)Q4 20253($0.96)($0.84)($0.89)FY 202512($3.90)($3.48)($3.67)BEAM Earnings Date and InformationBeam Therapeutics last issued its earnings results on August 6th, 2024. The reported ($1.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.13) by $0.02. The business had revenue of $11.80 million for the quarter, compared to analyst estimates of $14.18 million. Its revenue was down 41.3% compared to the same quarter last year. Beam Therapeutics has generated ($1.78) earnings per share over the last year (($1.78) diluted earnings per share). Earnings for Beam Therapeutics are expected to grow in the coming year, from ($4.60) to ($4.43) per share. Beam Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based off prior year's report dates.Read More Beam Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/13/2024(Estimated)------- 8/6/2024Q2 2024($1.13)($1.11)+$0.02($1.11)$14.18 million$11.80 million 5/7/2024Q1 2024($1.42)($1.21)+$0.21($1.21)$17.09 million$7.40 million 2/27/2024Q4 2023($0.69)$1.73+$2.42$1.73$34.16 million$316.20 million 11/8/2023Q3 2023($1.33)($1.22)+$0.11($1.22)$17.09 million$17.20 million 8/8/2023Q2 2023($1.42)($1.08)+$0.34($1.08)$17.32 million$20.12 million 5/10/2023Q1 2023($1.36)($1.33)+$0.03($1.33)$14.41 million$24.21 million The world’s smartest man is in their crosshairs (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows,2/28/2023Q4 2022($1.34)($0.54)+$0.80($0.54)$12.73 million$20.04 million 11/7/2022Q3 2022($1.30)($1.56)($0.26)($1.56)$7.15 million$15.80 million 8/9/2022Q2 2022($1.08)($1.02)+$0.06($1.02)$9.44 million$16.65 million 5/9/2022Q1 2022($1.10)($1.01)+$0.09($1.01)$44.15 million$8.40 million 2/28/2022Q4 2021($1.02)($0.85)+$0.17($0.75)$9.58 million$51.07 million 11/7/2021Q3 2021($0.72)($0.42)+$0.30($0.42)$15.88 million$0.76 million 8/9/2021Q2 2021($0.74)($1.23)($0.49)($0.67)$8.33 million$0.01 million 5/10/2021Q1 2021($0.74)($3.35)($2.61)($3.35)$6.00 million$0.01 million 3/14/2021Q4 2020($0.66)($1.69)($1.03)$0.25$6.00 million$0.01 million 11/10/2020Q3 2020($0.57)($0.69)($0.12)($0.69)$0.01 million$0.01 million11/10/2020Q3 2020($0.55)($0.69)($0.14)($0.69)$0.01 million$0.01 million 8/12/2020Q2 2020($0.56)($0.69)($0.13)($0.69)$0.01 million$0.01 million8/12/2020Q2 2020($0.52)($0.69)($0.17)($0.69)$0.01 million$0.01 million 5/12/2020Q1 2020($0.55)($1.03)($0.48)($1.03)-$0.01 million5/12/2020Q1 2020($0.51)($1.03)($0.52)($1.03)-$0.01 million Beam Therapeutics Earnings - Frequently Asked Questions When is Beam Therapeutics's earnings date? Beam Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based off last year's report dates. Learn more on BEAM's earnings history. Did Beam Therapeutics beat their earnings estimates last quarter? In the previous quarter, Beam Therapeutics (NASDAQ:BEAM) reported ($1.11) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.13) by $0.02. Learn more on analysts' earnings estimate vs. BEAM's actual earnings. How can I listen to Beam Therapeutics's earnings conference call? The conference call for Beam Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Beam Therapeutics's conference call transcript? The conference call transcript for Beam Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Beam Therapeutics generate each year? Beam Therapeutics (NASDAQ:BEAM) has a recorded annual revenue of $352.57 million. How much profit does Beam Therapeutics generate each year? Beam Therapeutics (NASDAQ:BEAM) has a recorded net income of -$132.53 million. BEAM has generated -$1.78 earnings per share over the last four quarters. What is Beam Therapeutics's EPS forecast for next year? Beam Therapeutics's earnings are expected to grow from ($4.60) per share to ($4.43) per share in the next year. More Earnings Resources from MarketBeat Related Companies: NTLA Earnings EDIT Earnings SGMO Earnings ALVR Earnings DTIL Earnings RGEN Earnings EXEL Earnings RVMD Earnings HALO Earnings KRYS Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Micron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit Outlook This page (NASDAQ:BEAM) was last updated on 9/30/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWhat is Nvidia’s New $1 Trillion SuperProject?Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredForget ChatGPT: Follow the AI Retirement PlaybookEveryone’s talking about AI right now, but I’ve been talking about it for years. Follow this two-part playb...Brownstone Research | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.Monument Traders Alliance | SponsoredUrgent 2024 Election Summit [link enclosed]With the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Beam Therapeutics Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Beam Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.